Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
Titel:
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
Auteur:
Platzbecker, Uwe Della Porta, Matteo Giovanni Santini, Valeria Zeidan, Amer M Komrokji, Rami S Shortt, Jake Valcarcel, David Jonasova, Anna Dimicoli-Salazar, Sophie Tiong, Ing Soo Lin, Chien-Chin Li, Jiahui Zhang, Jennie Giuseppi, Ana Carolina Kreitz, Sandra Pozharskaya, Veronika Keeperman, Karen L Rose, Shelonitda Shetty, Jeevan K Hayati, Sheida Vodala, Sadanand Prebet, Thomas Degulys, Andrius Paolini, Stefania Cluzeau, Thomas Fenaux, Pierre Garcia-Manero, Guillermo